Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

467
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
467

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abl kinase activation promotes axon initial segment disassembly and protein sorting defects in Alzheimer's disease.

BMC biology·2026
Same author

Apolipoprotein E-enriched protein corona enhances the blood-brain barrier transport of β-sheet-breaker peptide-functionalized gold nanoparticles.

Colloids and surfaces. B, Biointerfaces·2026
Same author

Corrigendum to "Attenuation of blood-brain barrier dysfunction by functionalized gold nanoparticles against amyloid-β peptide in an Alzheimer's disease-on-a-chip model" [Mater. Today Bio 35 (2025) 102453].

Materials today. Bio·2026
Same author

Exploiting mechanistic insights to improve the delivery of nanomaterials and extracellular vesicles to tumors.

Biomaterials advances·2025
Same author

Inhibition of β-Amyloid Aggregation by Perezone, a Sesquiterpene Quinone.

Chemistry & biodiversity·2025
Same author

Attenuation of blood-brain barrier dysfunction by functionalized gold nanoparticles against amyloid-β peptide in an Alzheimer's disease-on-a-chip model.

Materials today. Bio·2025

Related Experiment Video

Updated: Nov 5, 2025

Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods
10:46

Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods

Published on: May 2, 2016

7.0K

In vivo micro computed tomography detection and decrease in amyloid load by using multifunctionalized gold nanorods:

Francisco Morales-Zavala1, Pedro Jara-Guajardo, David Chamorro

  • 1Departamento de Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile. mkogan@ciq.uchile.cl.

Biomaterials Science
|May 13, 2021
PubMed
Summary

This study introduces a novel gold nanorod (GNR) nanosystem for Alzheimer's disease (AD) neurotheranostics. The system aids in diagnosis via micro-CT imaging and reduces amyloid load and inflammation after treatment.

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.9K
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.6K

Related Experiment Videos

Last Updated: Nov 5, 2025

Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods
10:46

Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods

Published on: May 2, 2016

7.0K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.9K
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.6K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Neuroscience

Background:

  • Nanosystems offer promising strategies for diagnosing and treating diseases like Alzheimer's disease (AD).
  • Current diagnostic and therapeutic approaches for AD face limitations in efficacy and specificity.

Purpose of the Study:

  • To develop and evaluate a novel neurotheranostic nanosystem for Alzheimer's disease.
  • To create a system capable of both in vivo diagnosis and therapeutic intervention for AD.

Main Methods:

  • Gold nanorods (GNRs) were functionalized with Ang2 and D1 peptides.
  • The GNRs were administered to wild-type and AD mice models (APPswe/PSEN1dE9).
  • In vivo diagnosis was performed using microcomputed tomography (micro-CT); therapeutic effects were assessed after one month of recurrent treatment.

Main Results:

  • The GNR-based nanosystem allowed for in vivo detection and differentiation between wild-type and AD mice via micro-CT within 15 minutes.
  • Recurrent treatment with the GNRs-D1/Ang2 nanosystem led to a reduction in brain amyloid load.
  • Treatment also resulted in decreased levels of inflammatory markers in the brain.

Conclusions:

  • The developed neurotheranostic nanosystem demonstrates significant potential for AD diagnosis and therapy.
  • This GNR-based system offers a dual diagnostic and therapeutic approach for Alzheimer's disease.
  • The findings support the advancement of nanomedicine for neurodegenerative disorders.